Implementation Guidelines - Federal Transit Administration - U.S. ...

evening contact telephone
numbers in Step 5 of Copy 2 of
the CCF. The signature attests to
the authenticity of the specimen
and information provided and the
integrity of the collection
process. Refusal to sign the form
does not constitute a refusal to
test, but should be noted by the
collector in the remarks section
of the form.
The employee is not to put any
additional personal information
on the CCF. The collector must
instruct the employee not to list
any medications that he or she is
currently taking on the CCF.
The employee may make notes
of medications on the back of the
employee copy (Copy 5) of the
CCF for his or her own personal
use, but they must not be
conveyed to anyone else in the
drug testing process.
20. The collector completes the
collector’s portion of the CCF by
printing his/her name, date and
time of the collection, entering
the name of the courier/delivery
service and signing the
certification statement. The CCF
is checked to make sure it is
complete and legible and the
employee is provided Copy 5 of
the form.
21. Both the primary specimen and
the split specimen must be sealed
along with Copy 1 of the CCF in
the appropriate pouches of the
plastic bag. The employee will
be notified that he/she can leave
and the plastic bag will be
readied for shipping to the
laboratory (e.g., using shipping
containers and following
procedures defined by the courier
service). The specimen should be
placed in secure storage until
picked up by the courier/delivery
service.
22. Copy 2 of the CCF will be sent to
the MRO and Copy 4 of the CCF
will be sent to the DER within 24
hours, or the next business day.
The specimen must be shipped to
the laboratory as soon as
possible, but no later than the 24
hours or the next business day.
Any urine specimen remaining after the
specimen bottles have been filled and sealed
should be discarded. If the agency tests for
drugs other than those specified by the FTA
regulation, a completely separate urine
collection with its own non-federal custody
and control form is required.
Split Sample. As described, the DOT
drug testing process requires that the urine
specimen be split and poured into two
specimen bottles. The split specimen
process provides the employee with the
option of having an analysis of the split
sample performed at a separate DHHS
laboratory should the primary specimen test
result come into question. The employee
has 72 hours after being informed by the
MRO of a non-negative test result (i.e.,
positive, adulterated, substitute) to request a
test of the split sample.
Insufficient Volume (§40.193,
§40.195). If an employee is unable to
provide 45 mL of urine, the collector will
discard the specimen and instruct the
employee that he/she has up to 3 hours to
provide another specimen with sufficient
volume. The 3-hour time period begins
when the insufficient quantity or empty cup
is presented to the collector. During the 3hour
period, the employee may consume up
to 40 ounces of fluid distributed reasonably
throughout the period. The employee’s
Chapter 7. Drug Testing Procedures 7-11 August 2002